Company Valuation: SMS Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 2,277 10,518 7,915 4,931 15,089 18,863
Change - 361.9% -24.75% -37.7% 206.01% 25.01%
Enterprise Value (EV) 1 3,752 12,660 10,082 7,398 17,536 21,556
Change - 237.37% -20.36% -26.62% 137.04% 22.93%
P/E 7.21x 16.8x 12.7x -69.9x 30.3x 27.3x
PBR 0.65x 2.56x 1.68x 1.07x 2.81x 2.95x
PEG - 0.2x -25.87x 1x -0x 0.8x
Capitalization / Revenue 0.55x 1.86x 1.52x 0.94x 2.13x 2.41x
EV / Revenue 0.91x 2.24x 1.94x 1.42x 2.47x 2.75x
EV / EBITDA 4.58x 10.3x 8.83x 13.7x 15x 15.5x
EV / EBIT 6.15x 12.5x 12.1x 32.5x 20.4x 20.5x
EV / FCF -64.8x -12.4x -44.8x -23.4x -70.3x -31x
FCF Yield -1.54% -8.04% -2.23% -4.27% -1.42% -3.22%
Dividend per Share 2 0.25 0.3 0.3 0.3 0.4 0.4
Rate of return 0.93% 0.24% 0.32% 0.52% 0.22% 0.19%
EPS 2 3.73 7.386 7.35 -0.8339 5.886 7.799
Distribution rate 6.7% 4.06% 4.08% -36% 6.8% 5.13%
Net sales 1 4,146 5,651 5,199 5,221 7,093 7,827
EBITDA 1 819.8 1,227 1,142 541.8 1,169 1,387
EBIT 1 609.7 1,014 830.7 227.3 860.1 1,049
Net income 1 315.7 625.3 622.2 -70.59 498.3 691.4
Net Debt 1 1,475 2,142 2,167 2,467 2,447 2,693
Reference price 2 26.90 124.25 93.50 58.25 178.25 212.78
Nbr of stocks (in thousands) 84,652 84,652 84,652 84,652 84,652 88,652
Announcement Date 9/8/20 9/8/21 9/7/22 9/7/23 9/6/24 9/6/25
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
35.43x6.66x23.08x0.89% 48.2B
17.52x2.19x9.9x1.48% 39.97B
28.56x4.06x16.85x0.57% 12.43B
27.71x3.37x17.45x0.91% 12.03B
19.17x3.41x11.88x3.76% 9.35B
9.79x2.26x5.85x4.42% 7.75B
30.59x4.01x18.65x0.15% 7.43B
15.85x2.08x6.73x3.18% 7.22B
Average 23.08x 3.51x 13.80x 1.92% 18.05B
Weighted average by Cap. 25.58x 4.11x 15.73x 1.48%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. SMSPHARMA Stock
  4. SMSPHARMA Stock
  5. Valuation SMS Pharmaceuticals Limited